[Gold preparations in therapy of rheumatoid and psoriatic arthritis].
Nasonova
V A
VA
Lukina
G V
GV
Sigidin
Ia A
IaA
Badokin
V V
VV
D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001310:Auranofin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D018849:Controlled Clinical Trials as Topic; D004311:Double-Blind Method; D006052:Gold Sodium Thiomalate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D010919:Placebos; D013997:Time Factors
D018501:Antirheumatic Agents; D010919:Placebos; D006052:Gold Sodium Thiomalate; D001310:Auranofin; D008727:Methotrexate